Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andrew J Lotery Simon P. Harding Helen Dakin Usha Chakravarthy |
| Publication date | July 29, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |